Tag: patent

  • Crop Biotech Acquires Genomic Engineering Technology

    29 July 2015. Calyxt Inc., a biotechnology company developing new varieties of food crops, is licensing technology from University of Minnesota for more efficient modification of plant genomes. Financial details of the agreement between Calyxt, in New Brighton Minnesota, and the university were not disclosed. Calyxt — until recently known as Cellectis Plant Sciences —…

  • Patent Awarded for Fractal Connections in Implants

    28 July 2015. Electronic microcircuits designed to resemble fractals in nature used in implanted medical devices received a patent from the U.S. Patent and Trademark Office. Patent number 9,079,017 was awarded on 14 July 2015 to physicist and materials scientist Richard Taylor at University of Oregon and Simon Brown at University of Canterbury in New…

  • Cancer Specialists Offer Plan to Reduce Drug Prices

    23 July 2015. A group of 118 cancer specialists proposed steps to reduce the cost of drugs to cancer patients, calling the current system of drug pricing “unsustainable and not affordable for many patients.” Their recommendations appear today in a commentary published in the journal Mayo Clinic Proceedings. Pharmaceutical industry representatives, however, say drugs play…

  • Patents Awarded to Women Rise, Particularly in Academia

    8 July 2015. Patents issued to women are still a minority at the U.S. Patent and Trademark Office, but their percentages increased over the past 4 decades, notably among recipients at academic institutions. A team of information technology and library science researchers from Indiana University, Simmons College in Boston, University of Washington, and Université de…

  • Internet-of-Things Security Architecture Designed

    19 June 2015. Engineering students at Ruhr-Universität Bochum in Germany are developing a security architecture to protect wireless communications among small household devices connected in what’s known as the Internet-of-Things. The team from the university’s Horst Görtz Institute that specializes in IT security is also receiving funds from a German government program to start a…

  • Anti-Infection Compound Devised for Dental, Wound Care

    18 June 2015. A new formulation of a common antibacterial agent can protect against infections for weeks or months at a time, according to its developers at University of Bristol in the U.K. The team led by Bristol dental materials scientist Michele Barbour is developing Pertinax, an extended antimicrobial compound, and receiving this year’s £25,000…

  • Report Evaluates Industry-Academic Biotech Partner Roles

    16 June 2015. A report released today by Biotechnology Industry Organization, or Bio, indicates academic research labs are playing an increasingly key role in research and development of new therapies, but it also highlights areas where partnerships between academia and industry are still evolving. Bio released the report, Advancing Translational Research for Biomedical Innovation: Measuring…

  • Patent Awarded for Early, Pre-Symptom Cancer Tests

    16 June 2015. Three researchers at Kansas State University in Manhattan received a patent for an early-stage test that the inventors say can diagnose some solid tumor cancers well before symptoms develop. Kansas State chemistry professor Stefan Bossmann and anatomy-physiology professor Deryl Troyer, with postdoctoral fellow Matthew Basel, received U.S. patent number 8,969,027 in March…

  • Injectable Neuro-Electronic Wire Mesh Demonstrated

    9 June 2015. Researchers at Harvard University developed a tiny electronic wire mesh that can be injected into the brain and demonstrated its diagnostic and therapeutic potential with lab mice. The team from the lab of chemistry professor Charles Lieber published its findings yesterday in the journal Nature Nanotechnology (paid subscription required, but full text…

  • FDA Approves Pediatric HIV Drug Formulation

    5 June 2015. The U.S. Food and Drug Administration approved an application for a current HIV drug formulated to better treat infections in infants and young children, especially in limited resource regions. The formulation is a combination of lopinavir and ritonavir in pellet form designed to mix with food, and manufactured by the generic drug…